Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab (STAR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by McMaster University
Sponsor:
Collaborators:
Hamilton Health Sciences Corporation
St. Joseph's Healthcare Hamilton
Information provided by (Responsible Party):
McMaster University
ClinicalTrials.gov Identifier:
NCT01243086
First received: November 5, 2010
Last updated: April 7, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)